6th OLOMOUC NEUROIMMUNOLOGY SYMPOSIUM
WITH INTERNATIONAL PARTICIPATION
September 16 – 17, 2010
Konvikt – Arts Centre, Palacký University, Olomouc
SYMPOSIUM‘S MAIN TOPICS:
- Modern trends in multiple sclerosis treatment
- Cerebrospinal fluid diagnostics in multiple sclerosis
- Nurse section
Programme
September 16, 2010
AUDITORIUM
Chairs: Havrdová E., Taláb R.
17.00 | Opening |
17.15 | New Treatment Options in MS |
18.00 | MRI in Therapy Optimisation |
19.00 | Welcome reception – Konvikt Courtyard – Arts centre of Palacký University |
September 17, 2010 – Morning Programme
AUDITORIUM
Chairs: Mareš J., Štourač P.
9.00 | Welcome and introduction to Day 2 |
9.15
| Multiple sclerosis: disease overview |
10.00 | Treatment guidelines and algorithms |
|
|
10.40 | Break |
|
|
11.00 | Merck Serono satellite symposium |
|
|
12.00 | Lunch |
September 17, 2010 – Afternoon Session I
AUDITORIUM: Modern trends in multiple sclerosis treatment I
Chairs: Havrdová E., Hradílek P.
13.00 | Have we changed our approach to MS in the past 10 years? |
13.15 | Monoclonal antibodies for multiple sclerosis treatment |
13.30 | New MS epidemiological data in Czech Republic |
13.45 | Multiple sclerosis and borreliosis: co-incidence or causal relationship? |
14.00 | Laser polarimetry with variable corneal compensation (GDx) measurements of thickness of the retinal layer of the optic nerve – a new method for the monitoring of degenerative changes in multiple sclerosis? |
14.15 | Myelin disorders and demyelination caused by a systemic disease or by side effects of immunomodulatory therapy |
14.30 | Demyelination and remyelination in multiple sclerosis |
|
|
14.45 | Break |
September 17, 2010 – Afternoon Session II
AUDITORIUM: Modern trends in multiple sclerosis treatment II
Chairs: Štourač P., Doležil D.
15.00 | Neurodegeneration and how to influence it in multiple sclerosis |
15.15 | Treatment for juvenile multiple sclerosis |
15.30 | Comprehensive monitoring of a patient with a clinically isolated syndrome |
15.45 | Treatment for aggressive multiple sclerosis |
16.00 | Two-year experience with natalizumab treatment in MS Centre, Department of Neurology, Faculty Hospital Královské Vinohrady, Praha |
16.15 | Measuring nerve fibre layer thickness in the retina of patients with multiple sclerosis and optic neuritis |
16.30 | Fingolimod – promising peroral drug for sclerosis multiplex treatment. Mechanism of action and results of clinical trials |
|
|
16.45 | Break |
September 17, 2010 – Afternoon Session III
LECTORIUM: CSF diagnostics in multiple sclerosis
Chairs: Adam P., Stejskal D.
13.00 | Importance of CSF investigations in multiple sclerosis |
13.15 | New opportunities in multiple sclerosis diagnostics using isoelectric focusing in IgA, IgM class and in FLC |
13.30 | The method and importance of macrophage oxidative burst detection in liquor diagnostics of central nervous system involvement |
13.45 | CSF inflammation and neurodegeneration markers in patients with cerebrospinal multiple sclerosis |
14.00 | Detection of increased light neurofilament subunit concentrations in cerebrospinal fluid of multiple sclerosis patients |
14.15 | Use of flow cytometry for the detection of cell subpopulations in cerebrospinal fluid |
14.30 | Current possibilities of laboratory medicine in diagnosing selected neurodegenerative diseases with a special emphasis on multiple sclerosis |
|
|
14.45 | Break |
September 17, 2010 – Afternoon Session IV
Cinema Hall: Nurse Session I
Chairs: Pyciaková L., Jonczyová V.
13.00 | Multiple sclerosis – disease characteristics |
13.15 | Therapeutic procedures in multiple sclerosis treatments |
13.30 | Modern trends in multiple sclerosis treatment – MxA. Devic’s disease |
13.45 | Natalizumab – mechanism of action and rules for its administration |
14.00 | Experimental treatment of malign relapsing-progressive forms of MS |
14.15 | Rehabilitation care in multiple sclerosis |
14.30 | Incidence and treatment of decubitus ulcers in patients with multiple sclerosis |
|
|
14.45 | Break |
September 17, 2010 – Afternoon Session V
Cinema Hall: Nurse Session II
Chairs: Kalandrová L., Řeháková P
15.00 | Clinical manifestation of multiple sclerosis |
15:15 | Neuropsychiatric manifestations in multiple sclerosis patients |
15:30 | Sexual dysfunction in MS patients |
15:45 | Paraclinical examination methods in MS – lumbar puncture |
16:00 | CSF examination in multiple sclerosis |
16:15 | Evoked potentials in MS, VEP |
16:30 | Living with multiple sclerosis |